Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiphospholipid antibodies.

M L Boey1

  • 1Medical Unit 4, Tan Tock Seng Hospital, Sigapore.

Annals of the Academy of Medicine, Singapore
|April 1, 1988
PubMed
Summary
This summary is machine-generated.

Antiphospholipid antibodies are common in systemic lupus erythematosus and other conditions. High levels link to thrombosis, thrombocytopenia, and recurrent abortions, but their exact immune role and treatment remain unclear.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Professor Feng Pao Hsii 31 October 1936-19 December 2015.

Lupus·2016
Same author

Atherogenic serum lipid profile is an independent predictor for gouty flares in patients with gouty arthropathy.

Rheumatology (Oxford, England)·2009
Same author

Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma.

Rheumatology (Oxford, England)·2007
Same author

Modelling variability of quality of life scores: a study of questionnaire version and bilingualism.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2004
Same author

Measuring health-related quality of life in Singapore: normal values for the English and Chinese SF-36 Health Survey.

Annals of the Academy of Medicine, Singapore·2002
Same author

A Chinese version of the Rheumatology Attitudes Index is a valid and reliable measure of learned helplessness in patients with SLE.

Lupus·2002
Same journal

"Gazing into the crystal ball of mortality prediction in conservative kidney care": Correspondence.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Vascular stiffness and sepsis mortality: A promising signal in search of clinical relevance.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Transcatheter aortic valve implantation for severe aortic regurgitation with Trilogy system: Initial Southeast Asia experience.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Singapore expert consensus on optimising lipid-lowering strategies in acute coronary syndrome: A modified Delphi study.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Association of estimated pulse wave velocity with 28-day mortality in sepsis: A MIMIC-IV study.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Prognostic value of the monocyte-to-albumin ratio in nasopharyngeal carcinoma: A retrospective cohort study.

Annals of the Academy of Medicine, Singapore·2026
See all related articles

Area of Science:

  • Immunology
  • Rheumatology

Background:

  • Antiphospholipid antibodies (APLA) are frequently observed in systemic lupus erythematosus (SLE).
  • APLA are not exclusive to SLE and can be present in other autoimmune and infectious diseases.
  • High APLA titers in SLE correlate with specific clinical and laboratory findings.

Purpose of the Study:

  • To review the prevalence and associations of antiphospholipid antibodies in systemic lupus erythematosus.
  • To highlight the diagnostic and clinical significance of APLA in SLE patients.
  • To discuss the current understanding and uncertainties regarding APLA immunology and management.

Main Methods:

  • Literature review of studies on antiphospholipid antibodies in systemic lupus erythematosus.
  • Analysis of associations between APLA and clinical manifestations like thrombosis and thrombocytopenia.

Related Experiment Videos

  • Synthesis of information on diagnostic markers and treatment considerations.

    • Main Results:

    • Antiphospholipid antibodies are prevalent in SLE, associated with lupus anticoagulant and false-positive VDRL tests.
    • High APLA levels in SLE correlate with increased risk of thrombosis, thrombocytopenia, and recurrent abortions.
    • APLA are found in various other conditions, including rheumatoid arthritis and syphilis.

    Conclusions:

    • Antiphospholipid antibodies play a significant role in the pathophysiology of SLE and related conditions.
    • The precise immunological mechanisms of APLA require further elucidation.
    • Optimal therapeutic strategies and treatment durations for APLA-positive patients remain to be definitively established.